4/6
10:11 pm
iova
Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback [Seeking Alpha]
Low
Report
Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback [Seeking Alpha]
3/31
04:48 am
iova
Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help [Seeking Alpha]
Medium
Report
Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help [Seeking Alpha]
3/26
05:49 am
iova
Iovance Biotherapeutics (IOVA) was upgraded by Truist Financial Corporation to "hold".
Low
Report
Iovance Biotherapeutics (IOVA) was upgraded by Truist Financial Corporation to "hold".
3/23
09:58 am
iova
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors [Yahoo! Finance]
Medium
Report
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors [Yahoo! Finance]
3/20
05:15 pm
iova
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3/13
11:11 pm
iova
Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas [Yahoo! Finance]
3/8
10:34 pm
iova
Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus [Yahoo! Finance]
Medium
Report
Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus [Yahoo! Finance]
3/7
08:17 pm
iova
Iovance (IOVA) Soars 33%, Hits All-Time High [Yahoo! Finance]
Medium
Report
Iovance (IOVA) Soars 33%, Hits All-Time High [Yahoo! Finance]
3/7
01:38 am
iova
Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target [Yahoo! Finance]
Medium
Report
Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target [Yahoo! Finance]
3/6
12:18 pm
iova
UBS Raises PT on Iovance Biotherapeutics (IOVA) [Yahoo! Finance]
Low
Report
UBS Raises PT on Iovance Biotherapeutics (IOVA) [Yahoo! Finance]
3/5
05:55 pm
iova
Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 [Yahoo! Finance]
High
Report
Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 [Yahoo! Finance]
3/5
10:24 am
iova
Iovance Biotherapeutics (IOVA) had its price target raised by UBS Group AG from $2.00 to $4.00. They now have a "neutral" rating on the stock.
High
Report
Iovance Biotherapeutics (IOVA) had its price target raised by UBS Group AG from $2.00 to $4.00. They now have a "neutral" rating on the stock.
3/3
08:50 am
iova
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "market outperform". They now have a $5.00 price target on the stock.
Low
Report
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "market outperform". They now have a $5.00 price target on the stock.
2/27
07:35 pm
iova
Iovance Biotherapeutics (IOVA) Reports 61% Annual Revenue Growth Driven by Amtagvi Success [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics (IOVA) Reports 61% Annual Revenue Growth Driven by Amtagvi Success [Yahoo! Finance]
2/27
04:21 pm
iova
Is Iovance Biotherapeutics (IOVA) Pricing Reflect Recent Cell Therapy Progress Accurately [Yahoo! Finance]
Low
Report
Is Iovance Biotherapeutics (IOVA) Pricing Reflect Recent Cell Therapy Progress Accurately [Yahoo! Finance]
2/26
08:00 am
iova
Iovance Biotherapeutics to Present at Upcoming Conferences
Low
Report
Iovance Biotherapeutics to Present at Upcoming Conferences
2/25
10:58 am
iova
Iovance Biotherapeutics (IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. They now have an "overweight" rating on the stock.
High
Report
Iovance Biotherapeutics (IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. They now have an "overweight" rating on the stock.
2/25
09:24 am
iova
Iovance Biotherapeutics (IOVA) had its price target lowered by Chardan Capital from $17.00 to $16.00. They now have a "buy" rating on the stock.
Medium
Report
Iovance Biotherapeutics (IOVA) had its price target lowered by Chardan Capital from $17.00 to $16.00. They now have a "buy" rating on the stock.
2/25
08:12 am
iova
Iovance Biotherapeutics Inc (IOVA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics Inc (IOVA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
2/25
08:00 am
iova
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "outperform". They now have a $5.00 price target on the stock.
Low
Report
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "outperform". They now have a $5.00 price target on the stock.
2/24
04:53 pm
iova
Iovance Biotherapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/24
03:51 pm
iova
Iovance Biotherapeutics: Better Gross Margin And Faster Turnaround Support A Higher Floor (Rating Upgrade) [Seeking Alpha]
Neutral
Report
Iovance Biotherapeutics: Better Gross Margin And Faster Turnaround Support A Higher Floor (Rating Upgrade) [Seeking Alpha]
2/24
01:06 pm
iova
Iovance Biotherapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
09:32 am
iova
Iovance Biotherapeutics Says Potential Sarcoma Therapy Shows 50% Response Rate in Pilot Clinical Trial [Yahoo! Finance]
High
Report
Iovance Biotherapeutics Says Potential Sarcoma Therapy Shows 50% Response Rate in Pilot Clinical Trial [Yahoo! Finance]
2/24
07:36 am
iova
Iovance Biotherapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
Iovance Biotherapeutics: Q4 Earnings Snapshot [Yahoo! Finance]